Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > MIT Enterprise Forum of Cambridge Presents Session on Life Sciences Marketplace Featuring Keynote With Dr. George Whitesides, Co-Founder of Genzyme

What: On March 12, the MIT Enterprise Forum of Cambridge will feature a keynote address by Dr. George Whitesides, life sciences pioneer, successful entrepreneur and currently the Woodford L. and Ann A. Flowers University Professor at Harvard University. Dr. Whitesides' presentation will be followed by a panel discussion with experts in life sciences, focusing on the challenges of collaborating on product development and commercializing technology.

MIT Enterprise Forum of Cambridge Presents Session on Life Sciences Marketplace Featuring Keynote With Dr. George Whitesides, Co-Founder of Genzyme

Cambridge, MA | Posted on March 6th, 2008

Dr. Whitesides is a co-founder of Genzyme and other companies whose combined market capitalization exceeds $20 billion. He has held advisory positions on the National Research Council, National Science Foundation and the Department of Defense's Defense Advanced Research Projects Agency (DARPA).

Following Dr. Whitesides' presentation, Stephen A. Bollinger, president and COO of Pervasis Therapeutics, will present a case study on his company, whose flagship product, Vascugel®, is an allogeneic cell therapy product that restores natural repair and regeneration pathways in the vasculature.

A panel made up of Dr. Ajan Reginald of F. Hoffmann-La Roche and Dr. Harlan Weisman of Johnson & Johnson will discuss the challenges of bringing the cultures and knowledge bases of the pharma, biologics, medical devices and cell therapy markets together to more effectively develop products and establish partnerships. Dr. Doug Levinson, a partner at Flagship Ventures, will serve as moderator.

Keynote Speaker:

Dr. Whitesides joined Harvard's department of chemistry in 1982 and served as department chairman from 1986 to 1989. Prior to joining Harvard, he was a member of the faculty of the Massachusetts Institute of Technology from 1963 to 1982. His present research interests include materials science, biophysics, surface science, polyvalency, microfluidics, optics, self-assembly, microfabrication, nanotechnology and cell surface biochemistry.

Other Speakers:

Dr. Ajan Reginald is global head of emerging technologies in the Roche Research Group of F. Hoffmann-La Roche. Dr. Reginald's group looks to identify the next generation of key biopharma and diagnostics technologies. Dr. Reginald joined Roche in 2005 as the business development director of mergers and acquisitions for Roche Pharma. Previously, Dr. Reginald founded Cosmetic Healthcare Group (CHG), which he later sold. He was awarded a Fulbright Scholarship for the MBA at Kellogg, Northwestern University, where he completed his Ph.D. in 2006.

Dr. Harlan Weisman is chief science and technology officer in the device and diagnostic unit of Johnson & Johnson. Dr. Weisman is a member of the Johnson & Johnson Medical Devices & Diagnostics Group Operating Committee (GOC) and supports the GOC in steering its scientific and technical agenda, leading its investments and sponsoring its research and development agenda. Previously, Dr. Weisman was assistant professor of medicine at Johns Hopkins University School of Medicine.

Dr. Doug Levinson is a partner at Flagship Ventures and focuses on investments in early-stage companies in the biotech industry. He is currently a director of T2 Biosystems after serving as founding CEO, and is on the Board of Resolvyx.

When: Wednesday, March 12, 2008

Networking: 5:30 p.m.

Program: 6:15-8:00 p.m.

Reception: 8:00-9:00 p.m.

Where: Stata Center (Bldg. 32), Kirsch Auditorium, 32 Vassar St., Cambridge

Sponsor: Foley Hoag LLP

Registration and information:

Forum members: $20; Non-members: $30; Students from all universities, free with college ID.


For more information, please click here

Regina Smith
MIT Enterprise Forum of Cambridge

Brad Baker (for MIT Enterprise Forum)

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

JPK announces expansion of its global sales and service activities in China and USA April 15th, 2014

Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014

PAM-XIAMEN Offers UV LED wafer April 15th, 2014

Engineers develop new materials for hydrogen storage April 15th, 2014


Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014

A molecular approach to solar power: Switchable material could harness the power of the sun — even when it’s not shining April 15th, 2014

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014


Engineers develop new materials for hydrogen storage April 15th, 2014

Near-field Nanophotonics Workshop in Boston April 14th, 2014

LetiDays Grenoble to Present Multiple Perspectives on Development, Challenges and Markets for the IoT April 14th, 2014

Iran to Hold 2nd National Conference on Nanotechnology in Power, Energy Industries April 13th, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE